Loading…
Business
Hosted by Unknown Host · Business · EN · 35 episodes
The Di Renzo Regulatory Affairs podcast for pharmaceutical companies, for manufacturers of medical devices, cosmetics, food supplements and disinfectants. News from our blog and from our weekly magazine ISI, Information Health.
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
39%
Guest openness
Selective
Sign up to generate a grounded pitch for Regulatory Affairs & Life Science.
Signup to Generate a PitchRegulatory Affairs & Life Science is a business podcast hosted by Unknown Host, with 35 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Unknown Host hosts Regulatory Affairs & Life Science, a business show with 35 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #10
The European Chemicals Agency (ECHA) has released a new draft guidance dedicated entirely to the identification and assessment of Substances of Concern (SoC) in biocidal products under the Biocidal Products Regulation (BPR - Regulation EU No 528/2012).In this episode, we break down this major regulatory update and what it means for the chemical and manufacturing industries.
Episode #9
A few years after the entry into force of Regulation (EU) 2017/745 (MDR), the European Commission is taking action to make the system more sustainable. With the amendment proposal COM(2025)1023 , Europe aims to cut red tape and boost the competitiveness of the medical sector—without compromising the strict safety standards of medical devices.In this podcast episode, we analyze the impact of this upcoming revision on manufacturers and industry operators. What we discuss in this episode: Process Digitalization: How the transition to electronic documentation and digital workflows (linked to EUDAMED) will reduce the paperwork burden. Flexibility for the PRRC: New opportunities for regulatory outsourcing—a breath of fresh air, especially for SMEs. Streamlining vs. Safety: What is changing on the administrative front and why clinical evaluation and post-market surveillance requirements remain as strict and unchanged as ever. Ongoing Challenges: The limited capacity of Notified Bodies and the structural bottlenecks that have yet to be resolved. 🎧 Tune in to find out how to guide your business through this regulatory evolution! 📌 To delve deeper into the topic, read our full blog post: Revision of Regulation (EU) 2017/745 (MDR): Impact on Manufacturers
Episode #8
As deadlines approach and new European obligations take effect, the proper management of medical devices requires unprecedented attention. In this episode, we clear up everything you need to know to successfully navigate EUDAMED registration (registrazione eudamed) without running into compliance roadblocks.We will break down the system's operational phases, explaining how to structure your data and correctly assign the UDI code (codice udi)—from the Basic UDI-DI all the way down to individual commercial packaging—to ensure full traceability and compliance with MDR and IVDR regulations. Whether you are a manufacturer, authorized representative, or importer, discover practical tips and essential steps to optimize your company's workflow and avoid bureaucratic delays.Happy listening! Listen to the episode and leave a comment with your regulatory questions.
Episode #7
When does a distributor or importer become, for all legal purposes, the MANUFACTURER of a medical device? In this episode, we shed light on one of the most complex, sensitive, and controversial aspects of the European Regulation on Medical Devices (MDR 2017/745) and the European Regulation on In Vitro Diagnostics (IVDR 2017/746): Article 16 . If you work in logistics, distribution, import, or compliance in the MedTech sector, you can't miss this episode. Let's analyze together: 👉 The 3 key scenarios in which the automatic change of legal role is triggered. 👉 The key exceptions (when label translation and repackaging do not alter your qualifications). 👉 The strict additional obligations for those who repackage (28-day advance notification and Quality Management System Certification). Avoiding sanctions or customs blockades on the market requires a thorough understanding of your economic roles. Listen to the episode to find out how to protect your business! Enjoy!
Episode #6
What happens before a drug reaches our hands or those of our animals? In this episode, we explore the beating heart of safety and compliance: GMP (Good Manufacturing Practice) audits in the pharmaceutical industry. Together with industry professionals, we analyze why these inspections aren't just bureaucratic procedures, but rather true safeguards for public health and business stability. We'll discover the concrete benefits for companies (and marketing authorization holders), what auditors really look for when they enter a manufacturing facility, and why—after the pandemic—on-site inspections have once again become an indispensable requirement compared to remote digital controls. If you work in the regulatory or quality sectors, or simply want to understand the rigorous standards behind the production of a human or veterinary medicinal product, this is the episode for you!
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
